login

Rho kinase blockade prevents inflammation via nuclear factor κB inhibition: evidence in Crohn’s disease and experimental colitis

GastroenterologyPublished 1 May 2003Open access
Jean‐Pierre Segain, Diane Raingeard de la Blétière, Vincent Sauzeau, Arnaud Bourreille, Gréory Hilaret, Chrystelle Cario‐Toumaniantz
Citations187
SJR quartileQ1
SJR score7.20
SNIP5.04
View PDF

TL;DR

This study provides the first evidence that Rho kinase activates I-kappa B kinase and, thus, nuclear factor kappa B, suggesting a key role of Rho Kinase in inflammatory responses and intestinal inflammation.

Abstract

Our study provides the first evidence that Rho kinase activates I-kappa B kinase and, thus, nuclear factor kappa B, suggesting a key role of Rho kinase in inflammatory responses and intestinal inflammation. Specific inhibition of Rho kinase may be a promising approach for the treatment of patients with Crohn's disease.

Keywords

MedicineBiochemistry, Genetics and Molecular Biology